| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae561449d2fbf5389fc47576384f67ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dfd7d7b19f58f45b6cf3cf0ea228035 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-025 |
| filingDate |
1997-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ccfb44e0cc553b760408f9015dc46c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2e2bf73a122e8a784c315caa56cc5e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a20a913fb01d3280b635e7e15c760447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928b22af43cce088b3757e1705595b47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e167b85da90284d1009dd3f9dff91c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_628b8b4d625992bc499ec77bdfa2ff16 |
| publicationDate |
1998-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2107496-C1 |
| titleOfInvention |
Method to treat diabetic angiopathy |
| abstract |
FIELD: medicine. SUBSTANCE: perfluorane is introduced once into patient's body but preliminary estimation of macro- and microdynamics nature of lower limbs should be conducted. At occlusion of main vessels perfluorane is injected intravenously at the dose of 200 ml. At occlusion of peripheral vessels perfluorane is preoxygenized for 5 minutes by gaseous oxygen to be injected into femoral artery of injured limb by punctures with the help of automatic batcher for medicinal substances. At infringed rheological blood properties anticoagulants or angioprotectors are additionally introduced. Method enables to decrease ischemic manifestations in a limb, demarcation area is developed at purulent-necrotic lesion of distal sections of a foot that creates ideal conditions for possible reconstructive interference upon vessels and favors to prevent pathological effect of ischemized limb inclusion into blood flow. EFFECT: higher efficiency of therapy. 2 cl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016384-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11491129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185523-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8974822-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0207717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9950067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8269027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8901174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6562872-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147859-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9604899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278621-B2 |
| priorityDate |
1997-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |